litigation

News

Gilead emerges victorious from HIV PrEP patent trial

A US court has sided with Gilead Sciences in a dispute with the US government centred on the use of HIV medicines for pre-exposure prophylaxis.

News

Gilead and US Government square up in court over PrEP

Gilead Sciences will go to court this week to argue that it does not need to pay the US Government a share of the profits it has made on the use of its HIV drugs for pre-e

News

Supreme Court presses pause on mifepristone curbs

The US Supreme Court has said it will allow the abortion pill mifepristone to remain available while an appeal of the decision to strike down its regulatory approval make

Sales & Marketing

Life sciences arbitration trends

The life sciences industry is seeing huge growth right now.

News

Relief for Amgen as it wins Otezla patent appeal

Amgen has won a crunch appeals court ruling that delays generic competition to its big-selling psoriasis drug Otezla in the US until 2028, although it missed out on gettin

News

Litigation costs pour cold water on J&J’s finances

Johnson & Johnson posted a loss in the first three months of the year as it booked a massive $6.9 billion charge related to its recently-agreed proposal to settle clai

Gilead emerges victorious from HIV PrEP patent trial

Gilead and US Government square up in court over PrEP

Supreme Court presses pause on mifepristone curbs

Life sciences arbitration trends

Relief for Amgen as it wins Otezla patent appeal

Litigation costs pour cold water on J&J’s finances

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

litigation

Editor's Picks